Peptides: Purity, Testing, and Sourcing

Peptide purity and sourcing quality are arguably more important than dosing protocols — a 200 mcg dose of degraded or mislabeled peptide delivers unknown biology. Understanding what testing methodologies mean, and what sourcing tiers exist, is foundational knowledge.

Testing Methodologies

HPLC (High-Performance Liquid Chromatography) separates the components of a peptide sample by passing it through a column under high pressure. The target peptide elutes at a specific retention time based on its physicochemical properties. The area under the peak, relative to all other peaks, gives the purity percentage. Typical measurement: UV absorbance at 220 nm (peptide bond absorption).

Mass Spectrometry (MS) measures the mass-to-charge ratio of ionized molecules. For peptides, it confirms: (1) the molecular weight matches the expected value for the claimed sequence, and (2) the dominant species is the target compound, not a truncated or modified sequence. MS is identity confirmation; HPLC is quantity/purity measurement. Both are required for a complete quality picture.

Source Type Comparison

Source Type	Typical Purity	Testing Documentation	Regulatory Status	Risk Level
FDA-approved pharmaceutical	99.5%+	Full GMP documentation, IND filing	FDA-approved, Rx required	Lowest — clinical-grade
Compounding pharmacy (503A)	98–99%	USP testing; pharmacist oversight	Legal with valid Rx; some peptides now excluded	Low — regulated
Reputable research vendor	98–99%	Third-party COA; HPLC + MS	Research chemical; “not for human use”	Moderate — variable QC
Unverified research vendor	90–98% (claimed)	Self-reported COA only	Research chemical; unverified	High — no independent verification
Underground / unknown	Unknown	None	Unregulated; no oversight	Highest — no traceability

What “99% Purity” Actually Contains

In a 5 mg (5000 mcg) vial at 99% purity:

• 4950 mcg = target peptide
• ~50 mcg = impurities: truncated sequences, deletion analogs, acetic acid (counter-ion), TFA (trifluoroacetic acid from synthesis), residual solvents

TFA is commonly present in research peptides as a counter-ion from HPLC purification. While generally regarded as low-toxicity at research doses, TFA-free or acetate-salt peptides are preferred for in vitro cell work and are increasingly offered by quality vendors.

Red Flags in Vendor Assessment

Vendors to avoid show these patterns: no third-party COA (only internal testing); COA that lists purity without HPLC chromatogram image; no MS data attached; price significantly below market (5 mg BPC-157 below ~$30 USD as of 2025 warrants scrutiny); no clear manufacturing origin or supplier chain; website with no contact information or physical address; customer reports of inactive batches.

The 25% Mislabeling Problem

Analysis of USADA/WADA positive cases attributed to supplement contamination (Judkins et al. 2022, PMID 35199458) and Cohen et al.’s post-recall supplement testing (PMID 25335153) consistently find that a substantial minority of products — approximately 25% in several analyses — contain unlabeled active substances or incorrect concentrations. While these studies focus on dietary supplements rather than research peptides specifically, the research chemical supply chain has less oversight, not more. Third-party testing is the only reliable protection.